3D Bio Therapeutics, Inc. 3DBio Therapeutics Receives Orphan Drug Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients November 19, 2019
Read More
3D Bio Therapeutics, Inc. 3DBio Therapeutics Receives Orphan Drug Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients November 19, 2019
Poseida Therapeutics, Inc. Poseida Therapeutics to Present Update on Approach in Allogeneic CAR-T at Society for Immunotherapy of Cancer 34th Annual Meeting November 5, 2019